1-7 of 7
Peter Falk
Close
Sort by
Journal Articles

Non-Myeloablative Conditioning Regimen (NMCR) for Allogeneic Bone Marrow Transplantation (BMT) in Patients with Severe Aplastic Anemia (SAA).

Joseph Rosenthal, MD, Anna Pawlowska, MD, Ellen Bolotin, MD, PhD, Peter Falk, MD, Cheryl Oliver, RN, Stephen Forman, MD
Journal: Blood
Blood (2007) 110 (11): 4943.
https://doi.org/10.1182/blood.V110.11.4943.4943
Published: 2007
Journal Articles

The Impact of Incorporating Targeted Radioimmunotherapy (RIT) into Transplant Preparative Regimens on the Incidence of Therapy Related Myelodysplasia (t-MDS) or AML (t-AML) Following Autologous Stem Cell Transplant (ASCT) for Lymphoma.

Amrita Y. Krishnan, MD, Joycelynne M. Palmer, PhD, Smita C. Bhatia, MD, MPH, Auayporn Nademanee, MD, Stephen J. Forman, MD, Andrew Raubitschek, MD, Arturo M. Molina, MD, Henry Fung, MD, Peter Falk, MD, Marilyn J. Slovak, MD, Nicole Tsai, MS, Jennifer Simpson, BA, Ravi Bhatia, MD
Journal: Blood
Blood (2007) 110 (11): 1082.
https://doi.org/10.1182/blood.V110.11.1082.1082
Published: 2007
Journal Articles

Fludarabine, Cyclophosphamide and ATG Based, Reduced Intensity Conditioning for HLA-Match Sibling Donor Transplant in Severe Aplasic Anemia (SAA) - Case Report.

Anna B. Pawlowska, MD, Ellen Bolotin, MD, Peter Falk, MD, Stephen Forman, MD, Joseph Rosenthal, MD
Journal: Blood
Blood (2006) 108 (11): 5370.
https://doi.org/10.1182/blood.V108.11.5370.5370
Published: 2006
Journal Articles

Low Risk of Relapse in Pediatric Patients after Double Unit Cord Blood Transplantation.

Joseph Rosenthal, MD, Ellen Bolotin, MD, Anna B. Pawlowska, MD, Peter Falk, MD, Stephen Forman, MD
Journal: Blood
Blood (2006) 108 (11): 5416.
https://doi.org/10.1182/blood.V108.11.5416.5416
Published: 2006
Journal Articles

New Transplant Strategies Utilizing Radioimmunotherapy (RIT) Based Regimens To Reduce Relapse in High Risk Mantle Cell Lymphoma (MCL).

Amrita Krishnan, MD, Andrew Raubitschek, MD, Stephen J. Forman, MD, Henry Fung, MD, Arturo Molina, MD, David Yamauchi, MD, Peter Falk, MD, Ricardo Spielberger, MD, Leslie Popplewell, MD, Roberto Rodriguez, MD, Pablo Parker, MD, Warren Chow, MD, Ryoto Nakamura, MD, Auayporn Nademanee, MD
Journal: Blood
Blood (2005) 106 (11): 681.
https://doi.org/10.1182/blood.V106.11.681.681
Published: 2005
Journal Articles

A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma

Clinical Trials & Observations
Auayporn Nademanee, Stephen Forman, Arturo Molina, Henry Fung, David Smith, Andy Dagis, Cheuk Kwok, Dave Yamauchi, Anne-Line Anderson, Peter Falk, Amrita Krishnan, Mark Kirschbaum, Neil Kogut, Ryotaro Nakamura, Margaret O'Donnell, Pablo Parker, Leslie Popplewell, Vinod Pullarkat, Roberto Rodriguez, Firoozeh Sahebi, Eileen Smith, David Snyder, Anthony Stein, Ricardo Spielberger, Jasmine Zain, Christine White, Andrew Raubitschek
Journal: Blood
Blood (2005) 106 (8): 2896–2902.
https://doi.org/10.1182/blood-2005-03-1310
Published: 2005
Journal Articles

Evaluating the Clinical Efficacy of Increased Granulocyte Colony-Stimulation Factor (GCSF) in Patients Who Fail a Standard Dose Regimen during Peripheral Blood Stem Cell Collection.

Shirong Wang, MD, Nademanee Auayporn, MD, Park Hyun Soon, RN, Joy Fridey, MD, Jocelynne Palmer, PhD, Eileen Smith, MD, David Snyder, MD, George Somlo, MD, Ravi Bhatia, MD, Peter Falk, MD, Mark Kirschbaum, MD, Neil Kogut, MD, Amrita Krishnan, MD, Kim Margolin, MD, Ryotaro Nakamura, MD, Margaret O’Donnell, MD, Pablo Parker, MD, Leslie Popplewell, MD, Vinod Pullarkat, MD, Qian Dajun, PhD, Roberto Rodriguez, MD, Joseph Rosenthal, MD, Ricardo Spielberger, MD, Anthony Stein, MD, Dana Yee, MD, Jasmine Zain, MD, Stephen Forman, MD.
Journal: Blood
Blood (2004) 104 (11): 2926.
https://doi.org/10.1182/blood.V104.11.2926.2926
Published: 2004